Infectious Disease

Top Story

Canada finds case of ceftriaxone-resistant gonorrhea

Canada finds case of ceftriaxone-resistant gonorrhea
November 18, 2017

A patient in Canada was diagnosed this year with a gonorrhea infection that was resistant to ceftriaxone, one the last available treatments for the increasingly drug-resistant STD.

Ceftriaxone is one of only two drugs recommended by WHO and the CDC to treat gonorrhea, the other being azithromycin. The same dual therapy is recommended in Canada.

In the Journals Plus

Global syphilis prevalence declines over 3 decades

November 17, 2017
A new database of syphilis prevalence in the adult general population showed an overall decrease in every WHO region since 1990, according to researchers. “The…

HSS highlights recent progress against antibiotic resistance

November 17, 2017
As part of World Antibiotic Awareness Week, HHS has released a progress report summarizing achievements made during the first 2 years of implementing a national strategy…
In the Journals Plus

Treatment may prevent progressive brain injury in patients with HIV

November 17, 2017
Patients with HIV may experience changes in cognition and brain structure soon after seroconversion, but effective treatment can prevent or minimize progressive brain…
In the Journals

Group B streptococcus stillbirths, deaths remain high despite vaccine feasibility

November 16, 2017
Group B streptococcal infections are a major contributor to poor health in both mothers and children and is responsible for nearly 150,000 stillbirths and infant deaths…
More Headlines »
CME

HIV Curbside Consults – Volume II: Switching Antiretroviral Therapy in the Setting of Virologic Suppression

This activity is supported by an educational grant from ViiV Healthcare.

In this case-based video, Joseph J. Eron, Jr., MD and Eric S. Daar, MD discuss simplifying antiretroviral therapy in a…
More »
Meeting News

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

November 16, 2017
WASHINGTON — When diagnosed with
More »
Resource Centers
IDWeek

IDWeek

Video
Meeting News

VIDEO: Ibalizumab continues to suppress MDR HIV after 48 weeks

October 13, 2017
More »
Advertisement
Advertisement